![](/img/cover-not-exists.png)
The endocannabinoid system and rimonabant: a new drug with a novel mechanism of action involving cannabinoid CB1 receptor antagonism – or inverse agonism – as potential obesity treatment and other therapeutic use
S. Xie, M. A. Furjanic, J. J. Ferrara, N. R. McAndrew, E. L. Ardino, A. Ngondara, Y. Bernstein, K. J. Thomas, E. Kim, J. M. Walker, S. Nagar, S. J. Ward, R. B. RaffaVolume:
32
Year:
2007
Language:
english
Pages:
23
DOI:
10.1111/j.1365-2710.2007.00817.x
File:
PDF, 676 KB
english, 2007